13F-HR filed by PATHWAY CAPITAL MANAGEMENT, LP
PATHWAY CAPITAL MANAGEMENT, LP filed this 13F-HR for the quarter ended 2025-09-30, filed 2025-11-04, with 7 holding rows worth $20,342,604.
- Accession
- 0001214659-25-015847
- Filer
- CIK 1037353
- Filed
- 2025-11-04
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2025
A holdings report, 7 entries on the cover page, a total value of $20,342,604 stated on the cover page (in dollars after the unit check, H1), rows summing to $20,342,604 with VALUE read as dollars as filed, 13F file number 028-19862. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| HIMS & HERS HEALTH INC | 433000106 | COM CL A | 119,279 | $6,765,505 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 51,051 | $4,191,287 | dollars as filed | |
| GOODRX HLDGS INC | 38246G108 | COM CL A | 986,158 | $4,171,448 | dollars as filed | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 50,049 | $3,243,676 | dollars as filed | |
| PDD HOLDINGS INC SPONSORED ADS | 722304102 | ADR | 7,197 | $951,227 | dollars as filed | |
| NU HLDGS LTD | G6683N103 | ORD SHS CL A | 59,010 | $944,750 | dollars as filed | |
| NEUEHEALTH INC | 10920V404 | COM NEW | 11,201 | $74,711 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001214659-25-015847 | this filing | 2025-11-04 | acceptance time not in the bulk data set |